IDEXX Laboratories stock heads into the open after September 24 update

At the close on September 24, 2026, IDEXX Laboratories stock was set against a Nasdaq Composite close of 26,939.37, while the company announced a Fecal Dx test expansion in Germany.

IDEXX Laboratories stock closed at a substantiated USD value on Nasdaq on September 24, 2026, with the session change not available in the retrieved market data. The Nasdaq Composite closed at 26,939.37, up 3.34 points, or less than 0.1 percent, on the same session.

September 24, 2026 session context

IDEXX Laboratories, Inc. (ISIN US45168D1046) announced an expansion of its Fecal Dx antigen test in Germany on September 24, 2026. As Las Vegas Sun reported, the test now includes detection of Taeniid tapeworms, including Taenia and Echinococcus species, for IDEXX customers in Germany.

The Nasdaq Composite finished at 26,939.37 on September 24, 2026, while the S&P 500 ended at 7,704.13, down 1.90 points, or less than 0.1 percent. The Dow Jones Industrial Average fell 161.61 points, or 0.3 percent, to 51,349.98.

September 25, 2026 outlook

Market data released for September 25, 2026 include US economic calendar items, including August durable-goods orders and the final September University of Michigan consumer-sentiment reading. The Nasdaq Composite comparison remains relevant for IDEXX as a Nasdaq-listed healthcare stock.